Saltar al contenido
Merck
Todas las fotos(1)

Documentos

921610

Sigma-Aldrich

TissueFab® bioink 

(GelAlg)ma -Vis/405 nm

Sinónimos:

Alginate, Alginate bioink, Alginate methacrylamide, Alginate methacrylate, Alginate methacryloyl, Bioink, Sodium alginate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Código UNSPSC:
12352201
NACRES:
NA.23

Nivel de calidad

100

descripción

suitable for 3D bioprinting applications

esterilidad

sterile-filtered

formulario

viscous liquid (or gel)

impurezas

≤5 CFU/g Bioburden (Fungal)
≤5 CFU/g Bioburden (Total Aerobic)

color

colorless to pale yellow

tamaño de partícula

0.2 μm

mp

6.5-7.5

aplicaciones

3D bioprinting

temp. de almacenamiento

2-8°C

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Aplicación

TissueFab® - AlgMA-UV bioink is an alginate methacrylate based bioink for 3D bioprinting applications. The formulation is optimized for 3D bioprinting of tissues and constructs using extrusion based 3D bioprinters. The bioink can be can be used to bioprint cell-laden hydrogels in your desired shape without any supporting material. The crosslinking of printed structures can be done in a single step using visible light mediated photocrosslinking. This bioink has applications in 3D cell culture, tissue engineering, and regenerative medicine.

This bioink is derived from natural polymers - alginate and gelatin. Alginate also known as sodium alginate or alginic acid, is a natural biopolymer obtained from brown algae. Alginate is a natural polysaccharide widely used in tissue engineering. Gelatin contains bioactive peptide sequences similar to native extracellular matrix which promotes integrin mediated cell adhesion and MMP sensitive enzymatic degradation which are essential for cellular functions such as migration, proliferation and differentiation.

Envase

10 mL in glass bottle

Otras notas

  • Ready-to-use formulation optimized for high printing fidelity and cell viability, eliminating the lengthy bioink formulation development process
  • Includes step-by-step protocols
  • Suitable for different extrusion-based 3D bioprinter instruments

Información legal

TISSUEFAB is a registered trademark of Merck KGaA, Darmstadt, Germany

Código de clase de almacenamiento

10 - Combustible liquids

Clase de riesgo para el agua (WGK)

WGK 3

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Artículos

Bioink Selection for 3D Bioprinting

Bioinks enable 3D bioprinting of tissue constructs for drug screening and transplantation; select suitable bioinks for specific tissue engineering.

Recent Advances in 3D-Bioprinting-based Drug Screening

Learn how 3D bioprinting is revolutionizing drug discovery with highly-controllable cell co-culture, printable biomaterials, and its potential to simulate tissues and organs. This review paper also compares 3D bioprinting to other advanced biomimetic techniques such as organoids and organ chips.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico